KLE1615 sp900066985: A Species-Level Look at One Gut Community Member

A species-level look at one member of your gut community

The KLE1615 sp900066985 test analyzes genetic material from a small stool sample to identify which microorganisms live in your digestive tract and how abundant they are. Modern sequencing methods such as 16S rRNA profiling (bacterial marker genes) or whole-metagenome analysis (all microbial DNA) map both community members and their potential functions. This reveals diversity, the presence of beneficial and opportunistic species, and clues about metabolic capacity, like short-chain fatty acid production. Results reflect your current gut ecosystem, which naturally shifts with diet, stress, sleep, medications, and travel—more like a weather report than a fixed fingerprint.

Why this single-species lens is useful

Why this matters: your gut microbes help break down complex carbohydrates, produce vitamins and signaling molecules, train the immune system, maintain the gut barrier, and communicate with the brain through the gut–brain axis. Patterns of diversity and stability often signal a resilient system that handles dietary variety and stress well. While microbiome science is rapidly evolving, repeated findings link a balanced community with efficient digestion, lower inflammation, and steadier metabolic function.

Your gut microbiome interacts with nearly every system that keeps you feeling well. When the community tilts out of balance (dysbiosis), you may notice everyday problems—bloating after meals, irregular stools, food sensitivities, or skin flares. Testing can highlight whether the ecosystem shows lower diversity, a dip in beneficial genera like Bifidobacterium and Faecalibacterium, or an overrepresentation of inflammation-associated species. It also helps contextualize life events that push the microbiome around: a course of antibiotics, a low-fiber diet during travel, heavy training blocks, exam-week stress, or new medications that change gut motility or acid levels. In practical terms, a readable map of “who’s there and what they do” turns vague symptoms into patterns you and your clinician can actually work with.

Big picture, your gut’s microbes influence glucose handling, lipid metabolism, immune tone, and even how you perceive satiety. That’s why research often links microbial diversity with cardiometabolic health and more stable inflammatory signaling, though more research is needed to define individual thresholds. Regular microbiome testing is about pattern recognition over time—seeing how higher-fiber eating, fermented foods, prebiotic substrates, stress management, or GLP‑1–based therapy for weight management affect your microbial community. The goal isn’t a perfect score; it’s an informed baseline you can revisit, especially after major changes like pregnancy, a new endurance routine, or recovery from an infection. Results from the KLE1615 sp900066985 test are most meaningful when interpreted with your history and, when appropriate, integrated with markers such as hs‑CRP, fasting glucose, or fecal calprotectin to sharpen clinical context.

Translating your profile

Most results are presented as proportions of microbial species or functional pathways compared against reference cohorts. A balanced pattern typically shows higher overall diversity and a healthy representation of beneficial groups such as Bifidobacterium and Faecalibacterium. You may also see summaries of metabolic potential—like capacity to generate short-chain fatty acids (SCFAs) that nourish colon cells and support barrier integrity. Low diversity or marked dominance of certain species can signal imbalance relative to peers with similar age and diet patterns.

When results look “optimal,” it usually points to efficient breakdown of complex carbohydrates, robust SCFA production (especially butyrate), and quieter inflammatory signaling—features that often align with comfortable digestion and steadier energy. Optimal ranges vary widely; geography, food traditions, and genetics shape what “normal” looks like for you.

When results suggest dysbiosis, patterns may include reduced diversity, lower levels of keystone butyrate producers, or a tilt toward taxa that correlate with inflammation. These are not diagnoses; they are functional clues that warrant exploration. For example, lower SCFA potential suggests your microbes may have fewer tools to turn fiber into beneficial metabolites, which can influence stool form and gut barrier tone. If symptoms persist or red flags appear (unintentional weight loss, blood in stool, persistent fevers), medical evaluation is important.

Context matters. Stool testing reflects a snapshot of the distal gut, not the entire digestive tract. Findings are strongest when viewed alongside other biomarkers and tracked over time to see whether changes—like adding resistant starch, adjusting training load, improving sleep regularity, or recovering from antibiotics—shift the ecosystem in a supportive direction.

What can move your result

Practical notes and limitations: results can vary with recent antibiotics, colonoscopy prep, or high-dose probiotics; follow collection instructions closely to reduce variability. 16S profiling offers broad bacterial patterns, while metagenomics provides deeper species and functional insights, including some fungi and viruses, though detection limits differ by assay. Day-to-day fluctuations are normal, so trends across repeat testing are more reliable than a single data point. Life stage can influence interpretation—pregnancy and early childhood feature naturally evolving microbiomes—so compare like with like when reviewing reference ranges. As with any lab test, the KLE1615 sp900066985 test is most useful when interpreted with your clinician, your symptoms, and your goals in mind.